Chemours (CC) Tops Q4 EPS by 22c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
The Chemours Company Reports Fourth Quarter and Full Year 2017 Results; Robust Performance Across All Segments and Key Financial Metrics
February 14, 2018 4:15 PM EST
WILMINGTON, Del., Feb. 14, 2018 /PRNewswire/ --
Fourth Quarter 2017 Highlights
Net Sales of $1.6 billion, up 19% Net Income of $228 million, up $458 million with EPS of $1.19 per diluted share, up $2.45 per diluted share Adjusted Net Income of $229 million, up $196 million with Adjusted EPS of $1.19 per diluted share, up $1.01 per diluted share Adjusted EBITDA of $394 million, up 65%Full Year 2017 Highlights
Net Sales of $6.2 billion, up 15% Net Income of $746 million, up $739 million with EPS of $3.91 per diluted share, up $3.87 per diluted share Adjusted... More